Zobrazeno 1 - 10
of 248
pro vyhledávání: '"Julio Pow‐Sang"'
Autor:
Zhouping Wei Ph.D, Malinda Iluppangama M.S., Ph.D, Jin Qi M.D., Jung W. Choi M.D., Ph.D, Alice Yu M.D., Kenneth Gage M.D., Vaibhav Chumbalkar M.D., Jasreman Dhilon M.D., K. C. Balaji M.D., Satish Venkataperumal M.D., David J. Hernandez M.D., Jong Park Ph.D, Clement Yedjou Ph.D, Richard Alo Ph.D, Robert A. Gatenby M.D., Julio Pow-Sang M.D., Yoganand Balagurunanthan Ph.D
Publikováno v:
Cancer Control, Vol 31 (2024)
Dynamic contrast enhancement (DCE) imaging is a valuable sequence of multiparametric magnetic resonance imaging (mpMRI). A DCE sequence enhances the vasculature and complements T2-weighted (T2W) and Diffusion-weighted imaging (DWI), allowing early de
Externí odkaz:
https://doaj.org/article/b8a116ce83dc4a188f0d52d400de3ebc
Publikováno v:
Cancer Control, Vol 31 (2024)
Management of recurrent prostate cancer following radiotherapy and subsequent radical prostatectomy poses considerable challenges due to potential complications for patients. Focal therapies have emerged as a burgeoning approach in prostate cancer tr
Externí odkaz:
https://doaj.org/article/2edf5b65b1404c82a15976f434f348c0
Autor:
Roger Li MD, Julio Pow-Sang MD
Publikováno v:
Cancer Control, Vol 31 (2024)
Since the introduction of radical prostatectomy by Hugh Hampton Young in 1905, this surgery has undergone constant evolution. With increasing appreciation for the impact of functional preservation on cancer survivorship, urologists have been steadfas
Externí odkaz:
https://doaj.org/article/c586bd5d9b324f49a0bb8cfac4f6c527
Autor:
Angelina K. C. Fink, Amanda C. DeRenzis, Shivanshu Awasthi, Nawreen Jahan, Peter A. S. Johnstone, Julio Pow‐Sang, Javier Torres‐Roca, Daniel Grass, Daniel Fernandez, Arash Naghavi, Susan Tan, Brandon Manley, Roger Li, Michael Poch, Alice Yu, Nikki Little, Eppie Bass, Cesar E. Ercole, Evangelia Katsoulakis, Ryan Burri, Riley Smith, Nathanael B. Stanley, Susan T. Vadaparampil, Kosj Yamoah
Publikováno v:
Cancer Medicine, Vol 12, Iss 2, Pp 1869-1877 (2023)
Abstract Participation in cancer research trials by minority populations is imperative in reducing disparities in clinical outcomes. Even with increased awareness of the importance of minority patient inclusion in clinical research to improve cancer
Externí odkaz:
https://doaj.org/article/34ce927cf9124a16ad2aa168603939d3
Autor:
Maria Baldeon-Calisto, Zhouping Wei, Shatha Abudalou, Yasin Yilmaz, Kenneth Gage, Julio Pow-Sang, Yoganand Balagurunathan
Publikováno v:
Frontiers in Nuclear Medicine, Vol 2 (2023)
Prostate gland segmentation is the primary step to estimate gland volume, which aids in the prostate disease management. In this study, we present a 2D-3D convolutional neural network (CNN) ensemble that automatically segments the whole prostate glan
Externí odkaz:
https://doaj.org/article/b8890dfd9e604bf2b04fb0878d31df6c
Autor:
Hui-Yi Lin, Po-Yu Huang, Chia-Ho Cheng, Heng-Yuan Tung, Zhide Fang, Anders E. Berglund, Ann Chen, Jennifer French-Kwawu, Darian Harris, Julio Pow-Sang, Kosj Yamoah, John L. Cleveland, Shivanshu Awasthi, Robert J. Rounbehler, Travis Gerke, Jasreman Dhillon, Rosalind Eeles, Zsofia Kote-Jarai, Kenneth Muir, UKGPCS collaborators, Johanna Schleutker, Nora Pashayan, APCB (Australian Prostate Cancer BioResource), David E. Neal, Sune F. Nielsen, Børge G. Nordestgaard, Henrik Gronberg, Fredrik Wiklund, Graham G. Giles, Christopher A. Haiman, Ruth C. Travis, Janet L. Stanford, Adam S. Kibel, Cezary Cybulski, Kay-Tee Khaw, Christiane Maier, Stephen N. Thibodeau, Manuel R. Teixeira, Lisa Cannon-Albright, Hermann Brenner, Radka Kaneva, Hardev Pandha, The PRACTICAL consortium, Srilakshmi Srinivasan, Judith Clements, Jyotsna Batra, Jong Y. Park
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-15 (2021)
Abstract Risk classification for prostate cancer (PCa) aggressiveness and underlying mechanisms remain inadequate. Interactions between single nucleotide polymorphisms (SNPs) may provide a solution to fill these gaps. To identify SNP–SNP interactio
Externí odkaz:
https://doaj.org/article/e04a68afd0214bb2aaaa455915e1fc0c
Autor:
Nainesh Parikh, MD, MBA, Edward Keshishian, MD, Ayushman Sharma, MD, Monica Roca, MD, Brandon Manley, MD, Michael Poch, MD, G. Daniel Grass, MD, PhD, Javier Torres-Roca, MD, David Boulware, MS, MBA, Peter Johnstone, MD, Michael Montejo, MD, Johnna Smith, ARNP, Julio Pow-Sang, MD, Kosj Yamoah, MD, PhD
Publikováno v:
Advances in Radiation Oncology, Vol 5, Iss 5, Pp 905-909 (2020)
Purpose: Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) represents 90% of all chronic prostatitis cases and may occur after radiation therapy (RT) for localized prostate cancer. Medical therapy is effective in approximately 50% of cases,
Externí odkaz:
https://doaj.org/article/650deeb5524d49b4baaefd77e80d76e5
Autor:
Rohit Jain, Shari Pilon-Thomas, Anders Berglund, Roger Li, Jose Conejo-Garcia, James Mule, Jingsong Zhang, Ryan Putney, Logan Zemp, Jasreman Dhillon, Youngchul Kim, Daniel Grass, Michael Poch, Julio Pow-Sang, Wade Sexton, Scott Gilbert, Colin Dinney
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/d9849c44bbcb4598893709d8de59cd6f
Autor:
Hong Lu, Nestor A. Parra, Jin Qi, Kenneth Gage, Qian Li, Shuxuan Fan, Sebastian Feuerlein, Julio Pow-Sang, Robert Gillies, Jung W. Choi, Yoganand Balagurunathan
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Background: Multiparametric magnetic resonance imaging (mpMRI) has emerged as a non-invasive modality to diagnose and monitor prostate cancer. Quantitative metrics on the regions of abnormality have shown to be useful descriptors to discriminate clin
Externí odkaz:
https://doaj.org/article/82f7a960d715448a94ffb596d3412675
Autor:
Shivanshu Awasthi, G Daniel Grass, Javier Torres-Roca, Peter A S Johnstone, Julio Pow-Sang, Jasreman Dhillon, Jong Park, Robert J Rounbehler, Elai Davicioni, Alex Hakansson, Yang Liu, Angelina K Fink, Amanda DeRenzis, Jordan H Creed, Michael Poch, Roger Li, Brandon Manley, Daniel Fernandez, Arash Naghavi, Kenneth Gage, Grace Lu-Yao, Evangelia Katsoulakis, Ryan J Burri, Andrew Leone, Cesar E Ercole, Joshua D Palmer, Neha Vapiwala, Curtiland Deville, Timothy R Rebbeck, Adam P Dicker, William Kelly, Kosj Yamoah
Publikováno v:
J Natl Cancer Inst
Background Personalized genomic classifiers have transformed the management of prostate cancer (PCa) by identifying the most aggressive subsets of PCa. Nevertheless, the performance of genomic classifiers to risk classify African American men is thus